BlueTree Allied Angels
VC Fund
Wexford, United States
BlueTree Allied Angels is a regional group of accredited investors who invest in regional early-stage companies. This members-only organization is designed to operate as a network of private equity investors who meet on a monthly basis to evaluate and consider pre-institutional, early-stage investments.
- Total investments:
- 37
- Last investment:
- Lead investor:
- 16%
Last updated:
For AI agents: llms.txt
Industries BlueTree Allied Angels invests in
Stages BlueTree Allied Angels invests in
Countries BlueTree Allied Angels invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Catherine Mott
|
|||
Darrin Grove
|
|||
Eric Silver
|
|||
Raul Valdes-Perez
|
|||
Ray Milhem
|
|||
| See all 6 contacts → | |||
Investment Focus
Industry
- Health Care 11 (30%)
- Software 9 (24%)
- Biotechnology 9 (24%)
- Therapeutics 7 (19%)
- Medical Device 6 (16%)
Stage
- Seed 10 (27%)
- Series A 8 (22%)
- Series B 6 (16%)
- Funding Round 4 (11%)
- Angel 2 (5%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Catherine Mott
CEO/Founder
|
CEO/Founder | Total investments: 4 | Find email | |
|
Darrin Grove
Co-chair Software & Technology Deal Flow
|
Co-chair Software & Technology Deal Flow | Total investments: 0 | Find email | |
|
Eric Silver
Member
|
Member | Total investments: 0 | Find email | |
|
Raul Valdes-Perez
Member
|
Member | Total investments: 0 | Find email | |
|
Ray Milhem
Chairman, Membership Committee
|
Chairman, Membership Committee | Total investments: 0 | Find email | |
| See all 6 team members → | ||||
Investments
| Company | Description | Round | Links |
|---|---|---|---|
CytoAgents
|
CytoAgents is a clinical stage biotechnology company focused on the development of innovative pharmaceutical products for the treatment of life-threatening symptoms associated with Cytokine Release Syndrome (CRS), an overreaction of the immune system causing systemic inflammation also known as cytokine storm. | $7M / Series A / May 11, 2023 | |
ERIN
|
Erin is a smart employee referral platform that maximizes your employee referral program to produce higher-quality, longer-tenure candidates at a fraction of the cost of traditional recruitment.The company's clients can automatically keep employees in the loop with automated email and mobile notifications and remove the burden of employeereferrals for both employees and administrators when using an application platform that notifies employees about new positions, allows them to make referrals, and tracks referral bonuses.Founded in 2018, Erin is headquartered in Pittsburgh, Pennsylvania, United States. | $5M / Seed / Oct 05, 2022 | |
OndeCare
|
FamilyTech, HRTech | $774.7K / Pre-Seed / Feb 28, 2022 | |
C360 Technologies
|
C360 Technologies is a video technology that delivers quality non-stitched immersive video products to date. C360 is a different kind of 360/VR company. Unlike most, they don’t stitch or require multi-headed cameras to deliver our stunning 6K immersive broadcast and streaming video. They've worked in the industry since 2008 pioneeringoriginal 360 technologies that continue to deliver the highest quality, non-stitched immersive video in the world. Their live output for linear broadcast and OTT streaming platforms coupled with the industry's smallest pro-grade immersive camera is unique compared to others. C360 delivers multiple HD-SDI outputs directly to the broadcast backhaul for live television events while simultaneously delivering a 4K stream to the OTT platform for distribution across VR and second screen (magic screen) applications. Unlimited users are now empowered to independently control their camera location and P/T/Z during the live event.The company was founded in 2008 and is headquartered in Wexford, Pennsylvania. | Venture - Series Unknown / Jan 15, 2022 | |
Augment Therapy
|
Augment Therapy is designed by a pediatric physical therapist, Augment Therapy is an all-in-one solution to engage, motivate, and monitor kids needing therapeutic exercise. | $1.4M / Seed / Sep 22, 2021 | |
Edge Case Research
|
Edge Case is the trusted risk-management partner for companies building self-driving trucks, autonomous robotaxis, and smarter passenger cars. We help developers and operators measure, manage, and insure the risks posed by software driving in the real world. Our mission is to deliver the promise of safe autonomous mobility.It was founded in 2013and headquartered in Pittsburgh, Pennsylvania. | $12M / Series A / Sep 15, 2021 | |
|
OndeCare
|
FamilyTech, HRTech | $680K / Pre-Seed / Jun 07, 2021 | |
Gridwise
|
The Gridwise app is the leading business platform for gig economy drivers, helping them maximize their earnings and track their business performance all in one place. Their app empowers 100s of thousands of all US gig drivers to run their businesses with unique demand insights, earnings, and activity tracking, performance reporting, and amarketplace of gig worker benefits. | $3.3M / Seed / Feb 28, 2020 | |
Lindy Biosciences
|
Lindy Biosciences is a development-stage protein therapeutic formulations company. Our core technology produces spherical, dense, stable particles of a therapeutic protein. These protein particles are ideal for long-term storage, or for non-standard formulations such as suspension formulations (for high-concentration delivery of antibodies),encapsulation (for sustained/controlled release), or dry powder pulmonary delivery. | $1.6M / Series A / Sep 18, 2019 | |
|
Edge Case Research
|
Edge Case is the trusted risk-management partner for companies building self-driving trucks, autonomous robotaxis, and smarter passenger cars. We help developers and operators measure, manage, and insure the risks posed by software driving in the real world. Our mission is to deliver the promise of safe autonomous mobility.It was founded in 2013and headquartered in Pittsburgh, Pennsylvania. | $7M / Seed / Jun 13, 2019 | |
| See all 37 investments → | |||
Co-Investors
Innovation Works
6 deals together
Pittsburgh Life Sciences Greenhouse
5 deals together
Harbor Light Capital Partners
3 deals together
Life Science Angels
3 deals together
Next Act Fund
3 deals together
412 Venture Fund
2 deals together
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does BlueTree Allied Angels invest in?
BlueTree Allied Angels invests primarily in Health Care, Software and Biotechnology startups, most often at Seed and Series A stage. Most of the 37 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact BlueTree Allied Angels?
Public channels for BlueTree Allied Angels include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at BlueTree Allied Angels?
The team at BlueTree Allied Angels includes Catherine Mott (CEO/Founder), Darrin Grove (Co-chair Software & Technology Deal Flow) and Eric Silver (Member), among 6 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
